The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Open accessAbstract
BACKGROUND: Tigecycline is a novel glycylcycline that exhibits broad-spectrum antibacterial activity. Recently, the US FDA issued a warning concerning increased mortality with tigecycline in randomized controlled trials (RCTs). METHODS: We conducted a systematic review and meta-analysis of RCTs that compared tigecycline with any other antibiotic regimen for the treatment of any infection. A comprehensive search, without publication status or other restrictions, was conducted. The primary outcome was overall 30 day mortality. The secondary outcome included clinical and microbiological failure, superinfections and adverse events (AEs). The trials' risks of bias and their effects on results were assessed. Two reviewers independently extracted the data. Individual trials' relative risks (RRs) were pooled using a fixed effect meta-analysis. RESULTS: Fifteen trials (7654 patients) were included. Overall mortality was higher with tigecycline compared with other regimens [RR 1.29, 95% confidence interval (CI) 1.02-1.64, without heterogeneity]. The type of infection assessed and the trials' reported risks of bias did not affect this result. Clinical failure was significantly higher with tigecycline (RR 1.16, 95% CI 1.06-1.27) and non-statistically significant higher rates of microbiological failure were demonstrated (RR 1.13, 95% CI 0.99-1.30). Development of septic shock was significantly more frequent with tigecycline (RR 7.01, 95% CI 1.27-38.66). Superinfections were significantly more common with tigecycline and so were AEs, including all AEs and AEs requiring discontinuation. CONCLUSIONS: In the light of the increased mortality, probably explained by decreased clinical and microbiological efficacy, clinicians should avoid tigecycline monotherapy in the treatment of severe infections and reserve it as a last-resort drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 724
Self-citationEllis‐Grosse, E. J., Babinchak, T., Dartois, N., Rose, G., Loh, E., & Groups, T. 3. A. 3. C. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431675 · Cited by 414
Babinchak, T., Ellis‐Grosse, E., Dartois, N., Rose, G. M., Loh, E., & Groups, T. 3. A. 3. S. (2005) · Clinical Infectious Diseases · doi:10.1086/431676 · Cited by 381
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00006 · Cited by 332
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Rodvold, K. A., Gotfried, M. H., Cwik, M., Korth-Bradley, J. M., Dukart, G., & Ellis-Grosse, E. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl403 · Cited by 304
Pankey, G. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki248 · Cited by 301
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Freire, A. T., Melnyk, V., Kim, M. J., Datsenko, O., Dzyublik, O., Glumcher, F., Chuang, Y.-C., Maroko, R. T., Dukart, G., Cooper, C. A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.05.012 · Cited by 284
Tigecycline: A New Glycylcycline for Treatment of Serious Infections
Noskin, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/431672 · Cited by 226
Anthony, K. B., Fishman, N. O., Linkin, D. R., Gasink, L. B., Edelstein, P. H., & Lautenbach, E. (2008) · Clinical Infectious Diseases · doi:10.1086/526775 · Cited by 210
Karageorgopoulos, D. E., Kelesidis, T., Kelesidis, I., & Falagas, M. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn165 · Cited by 193
Breedt, J., Teras, J., Gardovskis, J., Maritz, F. J., Vaasna, T., Ross, D. P., Gioud-Paquet, M., Dartois, N., Ellis-Grosse, E. J., & Loh, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4658-4666.2005 · Cited by 192
Cai, Y., Wang, R., Liang, B., Bai, N., & Liu, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01402-10 · Cited by 189
A review of tigecycline — the first glycylcycline
Peterson, L. R. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70005-6 · Cited by 161
Oliva, M. E., Rekha, A., Yellin, A. E., Pasternak, J., Campos, M., Rose, G. M., Babinchak, T., Ellis‐Grosse, E. J., Loh, E., & the 301 Study Group (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-88 · Cited by 153
Sacchidanand, S., Penn, R. L., Embil, J. M., Campos, M. E. D. S., Curcio, D., Ellis‐Grosse, E. J., Loh, E., & Rose, G. M. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.05.003 · Cited by 152
Gordon, N. C., & Wareham, D. W. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn555 · Cited by 148
Florescu, I., Beuran, M., Dimov, R., Razbadauskas, A., Bochan, M. R., Fichev, G., Dukart, G., Babinchak, T., Cooper, C. A., Ellis‐Grosse, E. J., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn250 · Cited by 134
Bradford, P. A., Weaver‐Sands, D. T., & Petersen, P. J. (2005) · Clinical Infectious Diseases · doi:10.1086/431673 · Cited by 133
Tanaseanu, C. M., Bergallo, C., Teglia, O., Jasovich, A., Oliva, M. E., Dukart, G., Dartois, N., Cooper, C. A., Gandjini, H., & Mallick, R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.009 · Cited by 112
Passarell, J. A., Meagher, A. K., Liolios, K., Cirincione, B. B., Wart, S. A. V., Babinchak, T., Ellis‐Grosse, E. J., & Ambrose, P. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-07 · Cited by 107
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Burkhardt, O., Rauch, K., Kaever, V., Hadem, J., Kielstein, J. T., & Welte, T. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.01.015 · Cited by 106
Vasilev, K. A., Reshedko, G., Orăsan, R., Sánchez, M., Teras, J., Babinchak, T., Dukart, G., Cooper, A., Dartois, N., Gandjini, H., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn249 · Cited by 102
Bergallo, C., Jasovich, A., Teglia, O., Oliva, M. E., Lentnek, A. L., de Wouters, L., Zlocowski, J. C., Dukart, G., Cooper, A., & Mallick, R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.09.001 · Cited by 94
Gardiner, D., Dukart, G., Cooper, A., & Babinchak, T. (2009) · Clinical Infectious Diseases · doi:10.1086/648720 · Cited by 91
Frampton, J. E., & Curran, M. P. (2005) · Drugs · doi:10.2165/00003495-200565180-00008 · Cited by 66
Swoboda, S., Ober, M., Hainer, C., Lichtenstern, C., Seiler, C. M., Wendt, C., Hoppe‐Tichy, T., Büchler, M. W., & Weigand, M. A. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm541 · Cited by 59
Towfigh, S., Pasternak, J., Poirier, A., Leister, H., & Babinchak, T. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03122.x · Cited by 55
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
the 313 Study Group, Tanaseanu, C. M., Milutinovic, S., Calistru, P. I., Strausz, J., Zolubas, M., Chernyak, V., Dartois, N., Castaing, N., Gandjini, H., et al. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-44 · Cited by 55
Chen, Z., Wu, J., Zhang, Y., Wei, J., Leng, X.-S., Bi, J., Li, R., Yan, L., Quan, Z., Chen, X., et al. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-217 · Cited by 45
Dartois, N., Castaing, N., Gandjini, H., & Cooper, A. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.supplement-1.28 · Cited by 34
Townsend, M. L., Pound, M. W., & Drew, R. H. (2007) · PubMed Central · Cited by 19
Chuang, Y.-C., Chang, C., Aradhya, S., Bheerappa, N., Pai, V. M., Dartois, N., Jouve, S., & Cooper, A. (2011) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2010.04.002 · Cited by 17
Falagas, M. E., & Metaxas, E. I. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.73 · Cited by 17
Mallick, R., Sun, S. H., & Schell, S. R. (2007) · Surgical Infections · doi:10.1089/sur.2005.058 · Cited by 12
Petersen, P. J., Ruzin, A. V., Tuckman, M., & Jones, C. H. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.11.009 · Cited by 12
[Differences in the use of tigecycline between ICU patients and non-ICU patients].
Álvarez-Lerma, F., Blanco, L., Rodríguez, J. A. L., Grau, S., Conde‐Estévez, D., & Luque, S. (2010) · PubMed · Cited by 4
Daniel Curcio, J., Carlos Seas, R., Jasovich, A., Rebeca Northland, G., Arathoon, E., Eduardo Rodríguez, N., Ellis‐Grosse, E. J., Loh, E., & Angel Cooper, H. (2009) · Revista chilena de infectología · doi:10.4067/s0716-10182009000300005 · Cited by 1
Cited by
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Metadata
- Authors
- Yahav, D., Lador, A., Paul, M., & Leibovici, L.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-18
- Volume
- 66
- Issue
- 9
- Pages
- 1963-1971
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2146287754
- Cited by
- 266
- References
- 39
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.